Deka Biosciences secures $20m to advance product pipeline
Deka Biosciences has secured funding of $20m in a Series B2 financing round to advance the product pipeline.
Deka Biosciences has secured funding of $20m in a Series B2 financing round to advance the product pipeline.
What's Your Reaction?
